Genetic dissection of intermediate phenotypes as a way to discover novel cancer susceptibility alleles

Current Opinion in Genetics and Development

Volumn 20, Issue 3, 2010, Pages 308-314

  Carvajal Carmona, Luis G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MITOCHONDRIAL DNA;

CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME SIZE; COLORECTAL CANCER; DNA CONTENT; DNA REPAIR; DYSPLASIA; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; METHODOLOGY; MUTATIONAL ANALYSIS; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE TRAIT LOCUS; REVIEW; SAMPLE SIZE; TELOMERE; ALLELE; CHROMOSOME MAP; GENETIC PREDISPOSITION; GENETICS; MUTATION; NEOPLASM; PROCEDURES;

ALLELES; CHROMOSOME MAPPING; DNA REPAIR; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUTATION; NEOPLASMS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 77953614989     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2010.03.013     Document Type: Review

References (66)

1. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
2. Eeles R.A., Kote-Jarai Z., Al Olama A.A., Giles G.G., Guy M., Severi G., Muir K., Hopper J.L., Henderson B.E., Haiman C.A., et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009, 41:1116-1121.
3. Tomlinson I., Webb E., Carvajal-Carmona L., Broderick P., Kemp Z., Spain S., Penegar S., Chandler I., Gorman M., Wood W., et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007, 39:984-988.
4. Amos C.I., Wu X., Broderick P., Gorlov I.P., Gu J., Eisen T., Dong Q., Zhang Q., Gu X., Vijayakrishnan J., et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008, 40:616-622.
5. Song H., Ramus S.J., Tyrer J., Bolton K.L., Gentry-Maharaj A., Wozniak E., Anton-Culver H., Chang-Claude J., Cramer D.W., DiCioccio R., et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009, 41:996-1000.
6. Petersen G.M., Amundadottir L., Fuchs C.S., Kraft P., Stolzenberg-Solomon R.Z., Jacobs K.B., Arslan A.A., Bueno-de-Mesquita H.B., Gallinger S., Gross M., et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010, 42:224-228.
7. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., Hirschhorn J.N. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008, 9:356-369.
8. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
9. Pharoah P.D. Shedding light on skin cancer. Nat Genet 2008, 40:817-818.
10. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578.
11. Gunnell D., Okasha M., Smith G.D., Oliver S.E., Sandhu J., Holly J.M. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001, 23:313-342.
12. Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T., Magnusson K.P., Manolescu A., Karason A., Palsson A., Thorleifsson G., et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 2007, 39:1443-1452.
13. Walley A.J., Asher J.E., Froguel P. The genetic contribution to non-syndromic human obesity. Nat Rev Genet 2009, 10:431-442.
14. Meyre D., Delplanque J., Chevre J.C., Lecoeur C., Lobbens S., Gallina S., Durand E., Vatin V., Degraeve F., Proenca C., et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009, 41:157-159.
15. Visscher P.M. Sizing up human height variation. Nat Genet 2008, 40:489-490.
16. Sanna S., Jackson A.U., Nagaraja R., Willer C.J., Chen W.M., Bonnycastle L.L., Shen H., Timpson N., Lettre G., Usala G., et al. Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet 2008, 40:198-203.
17. Weedon M.N., Lettre G., Freathy R.M., Lindgren C.M., Voight B.F., Perry J.R., Elliott K.S., Hackett R., Guiducci C., Shields B., et al. A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat Genet 2007, 39:1245-1250.
18. Gudbjartsson D.F., Sulem P., Stacey S.N., Goldstein A.M., Rafnar T., Sigurgeirsson B., Benediktsdottir K.R., Thorisdottir K., Ragnarsson R., Sveinsdottir S.G., et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 2008, 40:886-891.
19. Stacey S.N., Sulem P., Masson G., Gudjonsson S.A., Thorleifsson G., Jakobsdottir M., Sigurdsson A., Gudbjartsson D.F., Sigurgeirsson B., Benediktsdottir K.R., et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009, 41:909-914.
20. Bishop D.T., Demenais F., Iles M.M., Harland M., Taylor J.C., Corda E., Randerson-Moor J., Aitken J.F., Avril M.F., Azizi E., et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009, 41:920-925.
21. Weedon M.N., Lango H., Lindgren C.M., Wallace C., Evans D.M., Mangino M., Freathy R.M., Perry J.R., Stevens S., Hall A.S., et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008, 40:575-583.
22. Gudbjartsson D.F., Walters G.B., Thorleifsson G., Stefansson H., Halldorsson B.V., Zusmanovich P., Sulem P., Thorlacius S., Gylfason A., Steinberg S., et al. Many sequence variants affecting diversity of adult human height. Nat Genet 2008, 40:609-615.
23. Boyd N.F., Dite G.S., Stone J., Gunasekara A., English D.R., McCredie M.R., Giles G.G., Tritchler D., Chiarelli A., Yaffe M.J., et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002, 347:886-894.
24. Boyd N.F., Guo H., Martin L.J., Sun L., Stone J., Fishell E., Jong R.A., Hislop G., Chiarelli A., Minkin S., et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007, 356:227-236.
25. Tamimi R.M., Cox D.G., Kraft P., Pollak M.N., Haiman C.A., Cheng I., Freedman M.L., Hankinson S.E., Hunter D.J., Colditz G.A. Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res 2007, 9:R18.
26. dos Santos Silva I., Johnson N., De Stavola B., Torres-Mejia G., Fletcher O., Allen D.S., Allen N.E., Key T.J., Fentiman I.S., Holly J.M., et al. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006, 15:449-455.
27. Diorio C., Brisson J., Berube S., Pollak M. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 2008, 17:880-888.
28. Patel A.V., Cheng I., Canzian F., Le Marchand L., Thun M.J., Berg C.D., Buring J., Calle E.E., Chanock S., Clavel-Chapelon F., et al. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One 2008, 3:e2578.
29. Verheus M., Maskarinec G., Woolcott C.G., Haiman C.A., Le Marchand L., Henderson B.E., Cheng I., Kolonel L.N. IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort. Int J Cancer 2009, Epub ahead of print doi:10.1002.ijc.25142.
30. Lee E., Haiman C.A., Ma H., Van Den Berg D., Bernstein L., Ursin G. The role of established breast cancer susceptibility loci in mammographic density in young women. Cancer Epidemiol Biomarkers Prev 2008, 17:258-260.
31. Tamimi R.M., Cox D., Kraft P., Colditz G.A., Hankinson S.E., Hunter D.J. Breast cancer susceptibility loci and mammographic density. Breast Cancer Res 2008, 10:R66.
32. Woolcott C.G., Maskarinec G., Haiman C.A., Verheus M., Pagano I.S., Le Marchand L., Henderson B.E., Kolonel L.N. Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort. Breast Cancer Res 2009, 11:R10.
33. Brower V. Breast density gains acceptance as breast cancer risk factor. J Natl Cancer Inst 2010, 102:374-375.
34. Winawer S.J., Zauber A.G., Gerdes H., O'Brien M.J., Gottlieb L.S., Sternberg S.S., Bond J.H., Waye J.D., Schapiro M., Panish J.F., et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996, 334:82-87.
35. Boland C.R., Luciani M.G., Gasche C., Goel A. Infection, inflammation, and gastrointestinal cancer. Gut 2005, 54:1321-1331.
36. Monsen U., Brostrom O., Nordenvall B., Sorstad J., Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol 1987, 22:214-218.
37. Mayberry J.F., Rhodes J., Newcombe R.G. Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J 1980, 280:84.
38. Cottet V., Pariente A., Nalet B., Lafon J., Milan C., Olschwang S., Bonaiti-Pellie C., Faivre J., Bonithon-Kopp C. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 2007, 133:1086-1092.
39. Ekbom A., Helmick C., Zack M., Adami H.O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233.
40. Houlston R.S., Webb E., Broderick P., Pittman A.M., Di Bernardo M.C., Lubbe S., Chandler I., Vijayakrishnan J., Sullivan K., Penegar S., et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008, 40:1426-1435.
41. Barrett J.C., Lee J.C., Lees C.W., Prescott N.J., Anderson C.A., Phillips A., Wesley E., Parnell K., Zhang H., Drummond H., et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009, 41:1330-1334.
42. Lindahl T., Wood R.D. Quality control by DNA repair. Science 1999, 286:1897-1905.
43. Wu X., Gu J., Spitz M.R. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res 2007, 67:3493-3495.
44. Wu X., Spitz M.R., Amos C.I., Lin J., Shao L., Gu J., de Andrade M., Benowitz N.L., Shields P.G., Swan G.E. Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res 2006, 66:5993-5996.
45. Beggs A.D., Hodgson S.V. The genomics of colorectal cancer: state of the art. Curr Genomics 2008, 9:1-10.
46. Roberts S.A., Spreadborough A.R., Bulman B., Barber J.B., Evans D.G., Scott D. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?. Am J Hum Genet 1999, 65:784-794.
47. Slagboom P.E., Droog S., Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994, 55:876-882.
48. Vasa-Nicotera M., Brouilette S., Mangino M., Thompson J.R., Braund P., Clemitson J.R., Mason A., Bodycote C.L., Raleigh S.M., Louis E., et al. Mapping of a major locus that determines telomere length in humans. Am J Hum Genet 2005, 76:147-151.
49. Shen J., Terry M.B., Gurvich I., Liao Y., Senie R.T., Santella R.M. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007, 67:5538-5544.
50. Broberg K., Bjork J., Paulsson K., Hoglund M., Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005, 26:1263-1271.
51. Andrew T., Aviv A., Falchi M., Surdulescu G.L., Gardner J.P., Lu X., Kimura M., Kato B.S., Valdes A.M., Spector T.D. Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am J Hum Genet 2006, 78:480-486.
52. Mangino M., Richards J.B., Soranzo N., Zhai G., Aviv A., Valdes A.M., Samani N.J., Deloukas P., Spector T.D. A genome-wide association study identifies a novel locus on chromosome 18q12.2 influencing white cell telomere length. J Med Genet 2009, 46:451-454.
53. Cawthon R.M. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009, 37:e21.
54. Lee H.C., Yin P.H., Lin J.C., Wu C.C., Chen C.Y., Wu C.W., Chi C.W., Tam T.N., Wei Y.H. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 2005, 1042:109-122.
55. Wu C.W., Yin P.H., Hung W.Y., Li A.F., Li S.H., Chi C.W., Wei Y.H., Lee H.C. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer 2005, 44:19-28.
56. Tseng L.M., Yin P.H., Chi C.W., Hsu C.Y., Wu C.W., Lee L.M., Wei Y.H., Lee H.C. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer 2006, 45:629-638.
57. Wang Y., Liu V.W., Xue W.C., Cheung A.N., Ngan H.Y. Association of decreased mitochondrial DNA content with ovarian cancer progression. Br J Cancer 2006, 95:1087-1091.
58. Xing J., Chen M., Wood C.G., Lin J., Spitz M.R., Ma J., Amos C.I., Shields P.G., Benowitz N.L., Gu J., et al. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst 2008, 100:1104-1112.
59. Andreu A.L., Martinez R., Marti R., Garcia-Arumi E. Quantification of mitochondrial DNA copy number: pre-analytical factors. Mitochondrion 2009, 9:242-246.
60. Cookson W., Liang L., Abecasis G., Moffatt M., Lathrop M. Mapping complex disease traits with global gene expression. Nat Rev Genet 2009, 10:184-194.
61. Schadt E.E., Molony C., Chudin E., Hao K., Yang X., Lum P.Y., Kasarskis A., Zhang B., Wang S., Suver C., et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008, 6:e107.
62. Myers A.J., Gibbs J.R., Webster J.A., Rohrer K., Zhao A., Marlowe L., Kaleem M., Leung D., Bryden L., Nath P., et al. A survey of genetic human cortical gene expression. Nat Genet 2007, 39:1494-1499.
63. Emilsson V., Thorleifsson G., Zhang B., Leonardson A.S., Zink F., Zhu J., Carlson S., Helgason A., Walters G.B., Gunnarsdottir S., et al. Genetics of gene expression and its effect on disease. Nature 2008, 452:423-428.
64. Marioni J.C., Mason C.E., Mane S.M., Stephens M., Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008, 18:1509-1517.
65. Freimer N., Sabatti C. The human phenome project. Nat Genet 2003, 34:15-21.
66. Gudmundsson J., Sulem P., Steinthorsdottir V., Bergthorsson J.T., Thorleifsson G., Manolescu A., Rafnar T., Gudbjartsson D., Agnarsson B.A., Baker A., et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007, 39:977-983.